HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genadi Iosava Selected Research

Bronchitis

11/2020Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Genadi Iosava Research Topics

Disease

4Multiple Myeloma
11/2021 - 05/2012
3Disease Progression
11/2020 - 05/2012
2Hemophilia A (Haemophilia)
08/2021 - 01/2021
2Neutropenia
01/2018 - 05/2012
1Frailty
11/2021
1Cough
11/2020
1Bronchitis
11/2020
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2020
1von Willebrand Diseases (von Willebrand's Disease)
01/2020
1Neoplasms (Cancer)
01/2018
1Anemia
01/2018
1Infections
01/2018
1Thrombocytopenia (Thrombopenia)
01/2018
1Residual Neoplasm
01/2018

Drug/Important Bio-Agent (IBA)

4Prednisone (Sone)FDA LinkGeneric
11/2021 - 05/2012
4Melphalan (Alkeran)FDA LinkGeneric
11/2021 - 05/2012
3Bortezomib (Velcade)FDA Link
11/2021 - 01/2018
3daratumumabIBA
11/2021 - 01/2018
2von Willebrand FactorIBA
01/2021 - 01/2020
2Factor VIII (Coagulation Factor VIII)IBA
01/2021 - 01/2020
1Factor VII (Proconvertin)IBA
08/2021
1marzeptacog alfa (activated)IBA
08/2021
1Factor VIIa (Activated Factor VII)IBA
08/2021
1Lenalidomide (CC 5013)FDA Link
05/2012

Therapy/Procedure

2Stem Cell Transplantation
11/2020 - 01/2018
2Therapeutics
11/2020 - 05/2012
1Drug Therapy (Chemotherapy)
11/2020
1Transplantation
05/2012